Features
VIEW ALLNews
VIEW ALL
STRIDE-10 Results Support Merck’s 21-Valent Pneumococcal Conjugate Vaccine
The phase 3 STRIDE-10 trial evaluated the safety and immunogenicity of V116 in pneumococcal vaccine-naive adults 50 years of age and older.
Most Moms-to-Be Interested in RSV Vaccination During Pregnancy
More than half are very likely to get vaccinated; vaccination rates higher for those who perceive RSV as serious
COVID-19 Treatment Guidelines Show Great Global Variance
Findings based on review of national versus WHO guidelines
US Measles Cases Reach 125, Surpassing Recent Peak in 2022
HealthDay News — Measles infections continue to spread across the country, with 125 cases now reported in 18 states, new US government data shows. That is more cases than were reported in all of 2022, the most recent annual peak for measles infections, the US Centers of Disease Control and Prevention reported Friday. So far this…
Meningococcal ABCWY Vaccine Candidate Under FDA Review
A regulatory decision is expected on February 14, 2025.